[
    [
        {
            "time": "",
            "original_text": "医药研发外包行业：高成长性依然，CRO龙头净利率再创新高",
            "features": {
                "keywords": [
                    "医药研发",
                    "外包行业",
                    "高成长性",
                    "CRO龙头",
                    "净利率",
                    "创新高"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "研发外包"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药研发外包行业：高成长性依然，CRO龙头净利率再创新高",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(300759.SZ)实际控制人的一致行动人龙泰康质押53万股",
            "features": {
                "keywords": [
                    "康龙化成",
                    "实际控制人",
                    "一致行动人",
                    "龙泰康",
                    "质押",
                    "53万股"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成(300759.SZ)实际控制人的一致行动人龙泰康质押53万股",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "里昂：重申康龙化成(03759)“买入”评级 目标价升56%至165.87港元",
            "features": {
                "keywords": [
                    "里昂",
                    "康龙化成",
                    "买入",
                    "目标价",
                    "上调",
                    "165.87港元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "里昂：重申康龙化成(03759)“买入”评级 目标价升56%至165.87港元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "大行评级|里昂：上调康龙化成(3759.HK)目标价至165.87港元评级“买入”",
            "features": {
                "keywords": [
                    "大行评级",
                    "里昂",
                    "康龙化成",
                    "目标价",
                    "上调",
                    "买入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "大行评级|里昂：上调康龙化成(3759.HK)目标价至165.87港元评级“买入”",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "最强赛道里的超级白马股，业绩增速超快，成长空间依然巨大",
            "features": {
                "keywords": [
                    "最强赛道",
                    "超级白马股",
                    "业绩增速",
                    "成长空间"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "最强赛道里的超级白马股，业绩增速超快，成长空间依然巨大",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成收入大幅增长，盈利表现更佳",
            "features": {
                "keywords": [
                    "康龙化成",
                    "收入增长",
                    "盈利表现"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成收入大幅增长，盈利表现更佳",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "北向资金增仓榜：25股持股量环比增加超30%",
            "features": {
                "keywords": [
                    "北向资金",
                    "增仓榜",
                    "持股量",
                    "环比增加",
                    "30%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金增仓榜：25股持股量环比增加超30%",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        }
    ]
]